How many years have GSK deliberately rejected IV relenza !!!
GSK came as close as you can in 2002 to giving Relenza back to BTA lock stock and barrel. What could of been.!!!
We still might manage 3.00 yet but it wont be MGMTs doing or lack of doing.
Hang on for the ride.
- Forums
- ASX - By Stock
- BTA
- intravenous zanamivir for h5n1 infection
intravenous zanamivir for h5n1 infection, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online